These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32995665)

  • 1. Anterior migration of intravitreal fluocinolone acetonide (Iluvien®) implant in a pseudophakic eye with intact posterior capsule.
    Alzaabi M; Taguri AH; Elbarky A
    Am J Ophthalmol Case Rep; 2020 Dec; 20():100922. PubMed ID: 32995665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleral fixation of fluocinolone acetonide implant.
    Tabandeh H; Rezaei K
    Am J Ophthalmol Case Rep; 2020 Sep; 19():100775. PubMed ID: 32577584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema.
    Pessoa B; Coelho J; Correia N; Ferreira N; Beirão M; Meireles A
    Ophthalmic Res; 2018; 59(2):68-75. PubMed ID: 29248913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal Fluocinolone Acetonide Implant (FAc, 0.19 mg, ILUVIEN®) in the Treatment of Patients with Recurrent Cystoid Macular Edema After Pars Plana Vitrectomy.
    Lima-Fontes M; Leuzinger-Dias M; Barros-Pereira R; Fernandes V; Falcão M; Falcão-Reis F; Rocha-Sousa A; Alves-Faria P
    Ophthalmol Ther; 2023 Feb; 12(1):377-388. PubMed ID: 36417092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Technique for Repositioning of a Migrated ILUVIEN(®) (Fluocinolone Acetonide) Implant into the Anterior Chamber.
    El-Ghrably IA; Saad A; Dinah C
    Ophthalmol Ther; 2015 Dec; 4(2):129-33. PubMed ID: 26199036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal fluocinolone acetonide implant for the treatment of persistent post-surgical cystoid macular edema in vitrectomized eyes.
    Miguel-Escuder L; Olate-Pérez Á; Sala-Puigdoners A; Moll-Udina A; Figueras-Roca M; Navarro-Angulo MJ; Adán A; Pelegrín L
    Eur J Ophthalmol; 2023 Jan; 33(1):NP23-NP27. PubMed ID: 34836464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN
    Syed YY
    Drugs; 2017 Apr; 77(5):575-583. PubMed ID: 28283896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BILATERAL INTRAVITREAL 0.19-MG FLUOCINOLONE ACETONIDE IMPLANT FOR PERSISTENT NONDIABETIC CYSTOID MACULAR EDEMA AFTER VITRECTOMY.
    Ong SS; Walter SD; Chen X; Thomas AS; Finn AP; Fekrat S
    Retin Cases Brief Rep; 2021 May; 15(3):261-265. PubMed ID: 30015770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenging Clinical Cases - A Walk Through Supplemental Therapy with Intravitreal Ranibizumab Therapy Following Treatment of Diabetic Macular Edema with the 0.19 mg Fluocinolone Acetonide Implant (ILUVIEN
    Pessoa B; Melo-Beirão J; Meireles A; Menéres P
    Int Med Case Rep J; 2020; 13():437-448. PubMed ID: 32982484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel intravitreal fluocinolone acetonide implant (Iluvien(®)) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case series.
    Schmit-Eilenberger VK
    Clin Ophthalmol; 2015; 9():801-11. PubMed ID: 25999689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-year results from the Retro-IDEAL study: Real-world data from diabetic macular edema (DME) patients treated with ILUVIEN
    Augustin AJ; Bopp S; Fechner M; Holz F; Sandner D; Winkgen AM; Khoramnia R; Neuhann T; Warscher M; Spitzer M; Sekundo W; Seitz B; Duncker T; Ksinsik C; Höh H; Gentsch D
    Eur J Ophthalmol; 2020 Mar; 30(2):382-391. PubMed ID: 30884972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal Fluocinolone Acetonide (ILUVIEN) Implant for the Treatment of Refractory Cystoid Macular Oedema After Retinal Detachment Repair.
    Alfaqawi F; Sarmad A; Ayesh K; Mitra A; Sharma A
    Turk J Ophthalmol; 2018 Jun; 48(3):155-157. PubMed ID: 29988755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of a migrated dexamethasone implant (Ozurdex) from the anterior chamber using an intravenous cannula.
    Ku JY; Mercieca K; Yau K
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34244184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluocinolone acetonide intravitreal implant (Iluvien®): in diabetic macular oedema.
    Sanford M
    Drugs; 2013 Feb; 73(2):187-93. PubMed ID: 23335133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fluocinolone acetonide (ILUVIEN®) micro-implant for chronic diabetic macular edema].
    Soubrane G; Behar-Cohen F
    J Fr Ophtalmol; 2015 Feb; 38(2):159-67. PubMed ID: 25601517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anterior Chamber Dislocation of Dexamethasone Implant in the Presence of Carlevale Sutureless Scleral Fixation Intraocular Lens.
    Stavrakas P; Gartaganis P; Totou S; Chalkiadaki E; Manousakis E; Karmiris E
    Case Rep Ophthalmol; 2023; 14(1):229-233. PubMed ID: 37383169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroids for Diabetic Macular Edema.
    Chawan-Saad J; Wu M; Wu A; Wu L
    Taiwan J Ophthalmol; 2019; 9(4):233-242. PubMed ID: 31942428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of data characterizing the clinical effectiveness of the fluocinolone intravitreal implant (ILUVIEN) in patients with diabetic macular edema from the real world, non-interventional ICE-UK study and the FAME randomized controlled trials.
    Holden SE; Kapik B; Beiderbeck AB; Currie CJ
    Curr Med Res Opin; 2019 Jul; 35(7):1165-1176. PubMed ID: 30569759
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy.
    Meireles A; Goldsmith C; El-Ghrably I; Erginay A; Habib M; Pessoa B; Coelho J; Patel T; Tadayoni R; Massin P; Atorf J; Augustin AJ
    Eye (Lond); 2017 May; 31(5):684-690. PubMed ID: 28085139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early adoption of the fluocinolone acetonide (FAc) intravitreal implant in patients with persistent or recurrent diabetic macular edema (DME).
    McCluskey JD; Kaufman PL; Wynne K; Lewis G
    Int Med Case Rep J; 2019; 12():93-102. PubMed ID: 31114396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.